<DOC>
	<DOC>NCT02201134</DOC>
	<brief_summary>Studying the feasibility of an initial sedation with inhalated sevoflurane during therapeutic hypothermia of cardiac arrests resuscitated patients.</brief_summary>
	<brief_title>SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia</brief_title>
	<detailed_description>Prospective clinical study in ICU with ventilated patients sedated with sevoflurane using the Mirus® and Anaconda® , establishing the feasibility of an initial sedation of patients resuscitated from cardiac arrest and treated with therapeutic hypothermia.</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Adult patients ventilated requiring therapeutic hypothermia in ICU Stable respiratory and hemodynamic conditions Epinephrine and norepinephrine infusion rate &lt; 1,5 g/kg/min Consent of patients or family Arterial line Patients resuscitated after cardiac arrest No Flow &lt; 10 min Low Flow &lt; 20 min Neutropenia &lt; 1 G/L Post traumatic cardiac arrest Contraindication of halogenated anesthesics Extra corporeal life support or intra aortic balloon pump Pregnant woman Hemodynamic instability Brain death defined by the disappearance of brain stem reflexes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cardiac arrest</keyword>
	<keyword>Therapeutic hypothermia</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Sedation</keyword>
	<keyword>Patient resuscitated from cardiac arrest</keyword>
	<keyword>Requiring sedation</keyword>
	<keyword>Adult patients</keyword>
	<keyword>Patient covered by french health care system</keyword>
</DOC>